- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Treatments in Alzheimer’s disease ; volume:264 ; number:2 ; day:24 ; month:1 ; year:2017 ; pages:416-418 ; date:2.2017
Journal of neurology ; 264, Heft 2 (24.1.2017), 416-418, 2.2017
- Keyword
-
Hirnkrankheit
Neuropsychiatrie
Nervenkrankheit
- Creator
-
Malik, G. A.
- Contributor
-
Robertson, N. P.
SpringerLink (Online service)
- DOI
-
10.1007/s00415-017-8395-1
- URN
-
urn:nbn:de:1111-20170228101
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Malik, G. A.
- Robertson, N. P.
- SpringerLink (Online service)
Other Objects (12)
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease
Endocytosis and Alzheimer’s disease
Disease-modifying treatments in Alzheimer’s disease
New treatments in Alzheimer’s disease
New approaches to symptomatic treatments for Alzheimer’s disease
Study partners: essential collaborators in discovering treatments for Alzheimer’s disease
ER stress and UPR in Alzheimer’s disease: mechanisms, pathogenesis, treatments
Correction to: New approaches to symptomatic treatments for Alzheimer’s disease
Can Digital Technology Advance the Development of Treatments for Alzheimer’s Disease?
Alzheimer’s Disease
Biomarkers in Alzheimer’s disease
Psychosis in Alzheimer’s Disease
Alzheimer's disease